Impact of isolated tumor cells in sentinel lymph nodes detected by immunohistochemical staining

European Journal of Surgical Oncology

Volumn 32, Issue 10, 2006, Pages 1175-1179

  Imoto, S ^a   Ochiai, A ^a   Okumura, C ^a   Wada, N ^a   Hasebe, T ^a  

^a NATIONAL CANCER CENTER HOSPITAL EAST   (Japan)

Author keywords

Breast cancer; Immunohistochemical staining; Isolated tumor cells; Sentinel lymph node

Indexed keywords

CYCLOPHOSPHAMIDE; CYTOKERATIN 19; EOSIN; FLUOROURACIL; HEMATOXYLIN; METHOTREXATE; TAMOXIFEN; UFT;

ARTICLE; AXILLARY LYMPH NODE; BREAST CANCER; CANCER PATIENT; CANCER SURVIVAL; CELL ISOLATION; CONTROLLED STUDY; FOLLOW UP; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE DISSECTION; MAJOR CLINICAL STUDY; MANAGED CARE; MICROMETASTASIS; PRIORITY JOURNAL; PROGNOSIS; SENTINEL LYMPH NODE BIOPSY; TUMOR CELL; TUMOR RECURRENCE;

ADULT; AGED; AXILLA; BREAST NEOPLASMS; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; LYMPH NODE EXCISION; LYMPH NODES; LYMPHATIC METASTASIS; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; PROGNOSIS; SENTINEL LYMPH NODE BIOPSY;

EID: 33751198071     PISSN: 07487983     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejso.2006.08.006     Document Type: Article

References (15)

1. Giuliano A.E., Haigh P.I., Brennan M.B., et al. Prospective observational study of sentinel lymphadenectomy without further axillary dissection in patients with sentinel node-negative breast cancer. J Clin Oncol 18 13 (2000) 2553-2559
2. Schrenk P., Haltzl-Griesenhofer M., Shamiyen A., and Waynad W. Follow-up of sentinel node negative breast cancer patients without axillary lymph node dissection. J Surg Oncol 77 (2001) 165-170
3. Veronesi U., Paganelli G., Vilae G., et al. A randomized comparison of sentinel-node biopsy with routine axillary dissection in breast cancer. N Engl J Med 349 6 (2003) 546-553
4. Naik A.M., Fey J., Gemignami M., et al. The risk of axillary relapse after sentinel lymph node biopsy for breast cancer is comparable with that of axillary lymph node dissection. Ann Surg 204 3 (2004) 462-471
5. Sobin L.H., and Wittekind C. TNM Classification of malignant tumours. 6th ed. (2002), John Wiley and Sons, New York pp. 9-13
6. Cserni G., Amendoeira I., Apostolikas N., et al. Pathological work-up of sentinel lymph nodes in breast cancer. Review of current data to be considered for the formulation of guidelines. Eur J Cancer 39 (2003) 1654-1667
7. Imoto S., Wada N., Hasebe T., Ochiai A., Ebihara S., and Moriyama N. Sentinel node biopsy for breast cancer patients in Japan. Biomed Pharmacother 56 1 Suppl (2002) S192-S195
8. Imoto S., and Hasebe T. Initial experience with sentinel node biopsy in breast cancer at the National Cancer Center Hospital East. Jpn J Clin Oncol 29 1 (1999) 11-15
9. Imoto S., Fukukita H., Murakami K., Ikeda H., and Moriyama N. Pilot study on sentinel node biopsy in breast cancer. J Surg Oncol 73 3 (2000) 130-133
10. Wada N., Imoto S., Hasebe T., Ochiai A., Ebihara S., and Moriyama N. Evaluation of intraoperative frozen section diagnosis of sentinel lymph nodes in breast cancer. Jpn J Clin Oncol 34 3 (2004) 113-117
11. Tsuda H., Hirohashi S., Shimosato Y., et al. Correlation between histologic grade of malignancy and copy number of c-erbB-2 gene in breast cancer. Cancer 65 8 (1990) 1794-1800
12. Goldhirsch A., Glick J.H., Gelber R.D., Coates A.S., and Senn H.J. Meeting highlights: international consensus panel on the treatment of primary breast cancer. J Clin Oncol 19 18 (2001) 3817-3827
13. Swenson K.K., Mahipal A., Nissen M.J., et al. Axillary disease recurrence after sentinel lymph node dissection for breast carcinoma. Cancer 104 9 (2005) 1834-1839
14. Fisher B., Jeong J.H., Anderson S., Bryant J., Fisher E.R., and Wolmark N. Twenty-five-year follow-up of a randomized trial comparing radical mastectomy, total mastectomy and total mastectomy followed by irradiation. N Engl J Med 347 8 (2002) 567-575
15. Degnim A.C., Griffith K.A., Sabel M.S., et al. Clinicopathologic features of metastasis in nonsentinel lymph nodes of breast cancer patients. Cancer 98 11 (2003) 2307-2315